Deciphering the Gut-Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

被引：0
|
作者：
Singh, Samradhi [1 ]
Kriti, Mona [1 ]
Catanzaro, Roberto [2 ]
Marotta, Francesco [3 ]
Malvi, Mustafa [4 ]
Jain, Ajay [4 ]
Verma, Vinod [5 ]
Nagpal, Ravinder [6 ]
Tiwari, Rajnarayan [1 ]
Kumar, Manoj [1 ]
机构：
[1] ICMR Natl Inst Res Environm Hlth, Bhopal Bypass Rd, Bhopal 462030, India
[2] Univ Catania, Univ Hosp Policlin G Rodol, Dept Clin & Expt Med, Internal Med Unit,Gastroenterol & Hepatol Serv, I-95123 Catania, Italy
[3] ReGenera Res Grp Aging Intervent, I-20144 Milan, Italy
[4] Choithram Hosp & Res Ctr Indore, Indore 452014, India
[5] Sanjay Gandhi Postgrad Inst Med Sci, Stem Cell Res Ctr, Dept Hematol, Lucknow 226014, India
[6] Florida State Univ, Coll Hlth & Human Sci, Dept Nutr & Integrat Physiol, Tallahassee, FL 32306 USA
来源：
LIVERS | 2024年 / 4卷 / 03期
关键词：
metabolic disorder; NAFLD; gut-liver axis; gut microbiome; hepatic steatosis; probiotics; ANTIBIOTIC-ASSOCIATED DIARRHEA; INTESTINAL PERMEABILITY; ADIPOSE-TISSUE; OBESE MICE; BILE-ACIDS; MICROBIOTA; PROBIOTICS; CHILDREN; HEALTH; INFLAMMATION;
D O I：
10.3390/livers4030032
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant global health issue. The condition is closely linked to metabolic dysfunctions such as obesity and type 2 diabetes. The gut-liver axis, a bidirectional communication pathway between the liver and the gut, plays a crucial role in the pathogenesis of NAFLD. This review delves into the mechanisms underlying the gut-liver axis, exploring the influence of gut microbiota, intestinal permeability, and inflammatory pathways. This review also explores the potential therapeutic strategies centered on modulating gut microbiota such as fecal microbiota transplantation; phage therapy; and the use of specific probiotics, prebiotics, and postbiotics in managing NAFLD. By understanding these interactions, we can better comprehend the development and advancement of NAFLD and identify potential therapeutic targets.
引用
收藏
页码：435 / 454
页数：20
相关论文
共 50 条
  • [21] Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
    Vachher, Meenakshi
    Kaur, Kohinoor
    Marothia, Manisha
    Burman, Archana
    Deepanjana
    Bansal, Savita
    HUMAN NUTRITION & METABOLISM, 2025, 40
  • [22] The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease
    Ducheix, Simon
    Montagner, Alexandra
    Theodorou, Vassilia
    Ferrier, Laurent
    Guillou, Herve
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (01) : 96 - 105
  • [23] The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
    Ji, Yun
    Yin, Yue
    Sun, Lijun
    Zhang, Weizhen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [24] Lactobacillus fermentumCQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice
    Mu, Jianfei
    Tan, Fang
    Zhou, Xianrong
    Zhao, Xin
    FOOD & FUNCTION, 2020, 11 (10) : 8707 - 8723
  • [25] Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis
    Liu, Xia
    Sun, Runzhou
    Li, Zhaozhen
    Xiao, Ruixin
    Lv, Pengfei
    Sun, Xiangrong
    Olson, Mark A.
    Gong, Yanling
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 711
  • [26] Targeting the gut-liver axis in liver disease
    Wiest, Reiner
    Albillos, Agustin
    Trauner, Michael
    Bajaj, Jasmohan S.
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 1084 - 1103
  • [27] Gut microbiota and non-alcoholic fatty liver disease: new insights
    Aron-Wisnewsky, J.
    Gaborit, B.
    Dutour, A.
    Clement, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 338 - 348
  • [28] Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats
    Zhao, Hui
    Gao, Xiang
    Liu, Zhizuo
    Zhang, Lei
    Fang, Xuan
    Sun, Jianping
    Zhang, Zhaofeng
    Sun, Yongye
    NUTRIENTS, 2022, 14 (22)
  • [29] Polyphenols improve non-alcoholic fatty liver disease via gut microbiota: A comprehensive review
    Mohammadhasani, Kimia
    Fard, Mohammad Vahedi
    Shahri, Ali Mottaghi Moghaddam
    Khorasanchi, Zahra
    FOOD SCIENCE & NUTRITION, 2024, 12 (08): : 5341 - 5356
  • [30] MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis
    Wang, Xu
    Shi, Linlin
    Wang, Xinping
    Feng, Yi
    Wang, Yuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 141 : 1013 - 1021
12345